MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,992,110 | -33.6% | 109,505 | +5.0% | 0.00% | -33.3% |
| Q2 2023 | $24,093,069 | +86.5% | 104,299 | +95.6% | 0.00% | +200.0% |
| Q1 2023 | $12,917,789 | -52.0% | 53,322 | -42.5% | 0.00% | -66.7% |
| Q4 2022 | $26,934,910 | +926.9% | 92,799 | +129.9% | 0.00% | – |
| Q3 2022 | $2,623,000 | +253.5% | 40,360 | +289.3% | 0.00% | – |
| Q2 2022 | $742,000 | -83.0% | 10,368 | -76.6% | 0.00% | – |
| Q1 2022 | $4,354,000 | +33.8% | 44,377 | +15.6% | 0.00% | – |
| Q4 2021 | $3,253,000 | +762.9% | 38,395 | +710.5% | 0.00% | – |
| Q3 2021 | $377,000 | -21.1% | 4,737 | -3.5% | 0.00% | – |
| Q2 2021 | $478,000 | -30.8% | 4,911 | -17.0% | 0.00% | – |
| Q1 2021 | $691,000 | +18.1% | 5,915 | +12.4% | 0.00% | – |
| Q4 2020 | $585,000 | -30.9% | 5,263 | -26.2% | 0.00% | – |
| Q3 2020 | $846,000 | -76.3% | 7,132 | -77.4% | 0.00% | -100.0% |
| Q2 2020 | $3,567,000 | +778.6% | 31,497 | +418.0% | 0.00% | – |
| Q1 2020 | $406,000 | -30.0% | 6,081 | -4.5% | 0.00% | – |
| Q4 2019 | $580,000 | -27.1% | 6,366 | -31.0% | 0.00% | – |
| Q3 2019 | $796,000 | -69.9% | 9,220 | -63.5% | 0.00% | – |
| Q2 2019 | $2,645,000 | -49.6% | 25,237 | -39.8% | 0.00% | -100.0% |
| Q1 2019 | $5,248,000 | +24.2% | 41,895 | +11.8% | 0.00% | – |
| Q4 2018 | $4,224,000 | -39.9% | 37,468 | +14.2% | 0.00% | -100.0% |
| Q3 2018 | $7,024,000 | -26.0% | 32,802 | -3.3% | 0.00% | 0.0% |
| Q2 2018 | $9,492,000 | +1076.2% | 33,938 | +390.9% | 0.00% | – |
| Q1 2018 | $807,000 | +407.5% | 6,913 | +297.8% | 0.00% | – |
| Q4 2017 | $159,000 | +278.6% | 1,738 | +82.9% | 0.00% | – |
| Q3 2017 | $42,000 | +68.0% | 950 | -39.0% | 0.00% | – |
| Q2 2017 | $25,000 | +2400.0% | 1,557 | +2631.6% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |